Literature DB >> 9001281

Population and occupational screening for obstructive sleep apnea: are we there yet?

M J Baumel1, G Maislin, A I Pack.   

Abstract

Several features of obstructive sleep apnea (OSA) suggest that it may be an appropriate disease for screening programs for general populations and more specific high-risk groups. Preliminary data suggest that OSA represents an important health problem in terms of high prevalence, increased levels of morbidity and mortality, and increased public safety risk. Furthermore, the chronicity of the disease and the relatively low levels of recognition of the disorder in the medical community suggest a potential for lead-time gains for screening programs. Specific groups that might be considered for screening programs include commercial vehicle operators, hazardous duty personnel, and certain groups of medical patients. The purpose of this clinical commentary is to consider the issues of population and specific group screening for OSA by reviewing the general principles of screening for chronic disease and then applying these principles specifically in the case of OSA. More extensive outcomes data relating levels of severity of the disorder to its potential adverse outcomes are needed and will assist in tailoring appropriate screening programs and determining the cost-effectiveness of screening various populations.

Entities:  

Mesh:

Year:  1997        PMID: 9001281     DOI: 10.1164/ajrccm.155.1.9001281

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Obstructive Sleep Apnea Syndrome in Company Workers: Development of a Two-Step Screening Strategy with a New Questionnaire.

Authors:  Michiel M Eijsvogel; Sytske Wiegersma; Winfried Randerath; Johan Verbraecken; Esther Wegter-Hilbers; Job van der Palen
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

2.  Obstructive sleep apnea and ischemic heart disease in southwestern US veterans: implications for clinical practice.

Authors:  Carol M Baldwin; Iris R Bell; Stefano Guerra; Stuart F Quan
Journal:  Sleep Breath       Date:  2005-09       Impact factor: 2.816

3.  The role of primary care physicans in sleep medicine.

Authors:  N C Netzer
Journal:  Sleep Breath       Date:  1997-03       Impact factor: 2.816

4.  Occupational status and sleep-disordered breathing in a sample of French males.

Authors:  L Mayeux; D Teculescu; B Montaut-Verient; J M Virion; J P Michaely; B Hannhart
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 5.  Acoustic reflection: review and clinical applications for sleep-disordered breathing.

Authors:  John S Viviano
Journal:  Sleep Breath       Date:  2002-09       Impact factor: 2.816

Review 6.  Risk of Occupational Accidents in Workers with Obstructive Sleep Apnea: Systematic Review and Meta-analysis.

Authors:  Sergio Garbarino; Ottavia Guglielmi; Antonio Sanna; Gian Luigi Mancardi; Nicola Magnavita
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 7.  The prevalence, cost implications, and management of sleep disorders: an overview.

Authors:  Jamil L Hossain; Colin M Shapiro
Journal:  Sleep Breath       Date:  2002-06       Impact factor: 2.816

8.  In-home, self-assembled sleep studies are useful in diagnosing sleep apnea in the elderly.

Authors:  Christian R Morales; Sharon Hurley; Lindsay C Wick; Bethany Staley; Frances M Pack; Nalaka S Gooneratne; Greg Maislin; Allan Pack; Indira Gurubhagavatula
Journal:  Sleep       Date:  2012-11-01       Impact factor: 5.849

9.  Effect of Obstructive Sleep Apnea on Bone Mineral Density.

Authors:  Shadan Sadaf; Mohammad Shameem; Sheelu Shafiq Siddiqi; Shahzad Anwar; Shahnawaz Mohd
Journal:  Turk Thorac J       Date:  2021-07

10.  Screening for severe obstructive sleep apnea syndrome in hypertensive outpatients.

Authors:  Indira Gurubhagavatula; Barry G Fields; Christian R Morales; Sharon Hurley; Grace W Pien; Lindsay C Wick; Bethany A Staley; Raymond R Townsend; Greg Maislin
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.